The Fact Checker is a page on Amino Axiom, a free research information platform that also hosts a compound library, a vendor directory, price comparison, a compare tool and keyword search. A researcher enters a written claim about a compound, and the page compares that claim with the published literature. It lives at the Fact Checker.
The page is an information aid. It does not make claims of its own about any compound, and it does not stand in for the primary papers. What it offers is a quick way to see how a particular statement sits against what has been published, so that a researcher knows where to read next.
Why does claim checking matter in incretin research?
Incretin research moves quickly, and the same few compound names circulate in papers, supplier listings, forum posts and slide decks. Claims travel with them: this compound engages two receptors, that one is lipidated, a third has a certain mass. Some of these are correct, some are stale, and some are a different compound's property attached to the wrong name.
The cost of a wrong claim is practical. A methods section that cites a receptor profile the compound does not have will not survive review. A purchasing request built on a misremembered mass will not match the first quality check. Checking a claim before it enters a document is cheaper than correcting it afterwards, and a structured tool makes the habit easier to keep.
How does the Fact Checker work, step by step?
The workflow is short. A researcher can follow the same sequence each time:
Write the claim as a single, specific statement, for example a statement about which receptors a named compound is reported to engage.
Open the Fact Checker and enter the statement in the input.
Read the output, noting which parts of the statement the literature appears to support and which parts it does not address.
Follow the sources the output points to and read the primary papers, checking the assay system and the readout.
Record the verified wording, with its source, in the project notes, and discard the original phrasing if it was loose.
The fourth step is the one that carries the weight. The page narrows the reading list; the reading is still the researcher's job.
What makes a claim easy to check?
Specificity decides how useful a result is. A statement such as "this compound is a strong metabolic peptide" gives the tool nothing definite to compare, and the output will be correspondingly loose. A statement such as "this compound is a dual agonist at the GLP-1 receptor and the glucagon receptor" names a compound, a property and the receptors involved, and can be set directly against published pharmacology.
A few habits help:
Name one compound per claim, using the name found in the literature.
State one property per claim, such as a receptor target, a structural feature or a physical constant.
Say what kind of evidence is meant, such as a cell-based assay or a structural analysis, when that is known.
Split compound statements into separate lines instead of chaining them with "and".
Chained claims are the main source of confusing output. If one half of a sentence is well supported and the other half is not, the result for the whole sentence is hard to read.
How would an incretin lab test claims about real compounds?
Take GLP-1. The catalog entry lists a molecular weight of 3337.73 g/mol, a formula of C151H226N40O46 and CAS 106612-94-6 (GLP-1 7-37). A lab drafting a methods section might write that native GLP-1 is a selective agonist at a single receptor. That is a checkable statement. The Fact Checker can be asked about it, and the researcher can then compare the output with the receptor pharmacology papers. The catalog values handle the physical constants separately: a claim that quotes a different mass for the 7-37 form can be tested against 3337.73 g/mol without involving the literature at all.
Now take mazdutide. The catalog lists an approximate molecular weight of 4599 g/mol, a formula of C207H317N45O65 and CAS 2259884-03-0. A common statement in discussion is that it engages both the GLP-1 receptor and the glucagon receptor. A researcher can check that statement, then read the cited work to see in what assay system it was reported. For a structural overview of the compound, the article on mazdutide as a GLP-1R and glucagon receptor dual agonist is a useful companion.
A third case is GLP-1(S), listed at 4113.58 g/mol with a formula of C187H291N45O59 and CAS 910463-68-2. A claim that it is a lipidated analog can be checked against the literature. The jump in mass and carbon count over native GLP-1 is consistent with an added moiety, but the catalog fields only show that a difference exists; the literature has to say what the difference is.
How should a result be read?
A result is best treated as a map of the literature on that claim, not a verdict. Three questions help when reading one.
First, is the claim supported in the system the researcher cares about? A finding in a receptor-binding assay does not transfer automatically to a different cell line or readout.
Second, how many independent sources sit behind the claim? One paper is a lead; several papers from different groups are firmer ground, though still not proof for a new experimental context.
Third, is anything missing? A result that addresses only part of the statement signals that the unaddressed part needs its own search.
The tool reports what it finds. It does not rank compounds, it does not judge whether any compound is worth studying, and it makes no claim about outcomes.
How can catalog fields and the Fact Checker work together?
The two cover different kinds of question. Catalog fields answer questions with a fixed value: formula, molecular weight, CAS number. The Fact Checker handles questions that depend on interpretation of published work, such as receptor profiles and structural features.
A sensible order is to check the fixed values first. If a claim cites a mass or a formula that does not match the catalog, that is a simple factual mismatch and needs no literature search. Once the constants agree, the remaining statements go to the Fact Checker. For a wider view of the compounds involved, the incretin research compound landscape for 2026 gives context on how the main scaffolds relate.
What are the limits of a fact-checking tool?
Three limits are worth stating plainly.
First, a tool compares a claim with what has been published and indexed. Recent work, unpublished work and work behind restricted access may be absent from the comparison.
Second, a short claim leaves out conditions. Potency, selectivity and similar terms depend on assay system, species and readout, and a one-line statement cannot carry all of them.
Third, the page does not substitute for expert review. A specialist reading the primary papers will see details a summary does not surface, and the primary literature remains the authority.
Where does the Fact Checker fit in a research workflow?
The most common point is drafting: before a claim goes into a manuscript, protocol or grant text, it is set against the literature. A second point is onboarding, where a new group member tests the statements they have inherited from older notes. A third is review, where a reader tests a claim in someone else's draft before commenting on it.
The platform's homepage at Amino Axiom lists the other surfaces it offers. For this article the relevant one is the Fact Checker, and the walkthrough above shows how it can be put to work on incretin-focused claims.
Research use disclaimer
All compounds referenced in this article are supplied for laboratory research use only. They are not intended for human or veterinary use, and nothing here describes or implies any use outside in vitro and other controlled research settings. Descriptions of Amino Axiom reflect only what its Fact Checker page visibly presents. For research purposes only.
Reference
Common questions
The Amino Axiom Fact Checker is a free page that takes a written claim about a compound and compares it with the published literature. It is a research information tool. It points a reader toward what the literature says and does not replace reading the primary papers or a lab's own verification work.
Narrow, checkable statements suit it best, such as which receptors a compound is reported to engage, whether a sequence is lipidated, or what a molecular weight is. Broad or vague statements give vague results. Splitting a long claim into single statements usually makes the output easier to read and verify.
No. The tool summarizes how a claim relates to published work, but a summary is not the source. Researchers should open the cited papers, check the assay system and readout, and confirm that the finding applies to their own context before relying on it in a methods section.
Catalog fields such as molecular formula, molecular weight and CAS number give fixed reference values. A claim that cites a mass or formula can be compared against the catalog entry first, which separates simple factual mismatches from questions that need the pharmacology literature.
